VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DMRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DMRADamora Therapeutics, Inc.
$22.56$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDMRAQuarterly Cash Flow

Damora Therapeutics, Inc. (DMRA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Damora Therapeutics, Inc. (DMRA) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

DMRA Cash Flow Statement

Quarterly statement

DMRA Cash Flow Statement

Damora Therapeutics, Inc. (DMRA) cash flow statement — 8-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-17.23M-21.87M-20.6M566K------4.1M-5.94M-11.47M-8.45M-7.85M-9.13M-11.45M-9.85M-14.84M-6.8M-17.83M
Operating CF Margin %--------------------
Operating CF Growth %----------35.01%-0.23%14.15%47.11%-34.38%35.79%-7.51%-32.87%51.97%-22.81%
Net Income-31.99M-31.17M-27.78M-200.74M------5.34M-5.48M-6.47M-8.14M-10.74M-12.99M-14.07M-13.73M-16.89M-16.94M-13.41M
Depreciation & Amortization5K11K68K7K-----77K98K229K367K95K139K164K104K104K118K111K
Stock-Based Compensation7.54M00483K-----01.36M1.09M1.46M1.44M1.43M1.35M1.4M1.42M1.4M1.24M
Deferred Taxes0000-----00000000000
Other Non-Cash Items-784K6.14M3.13M183.67M-----980K-8K-83K-148K-80K-138K141K17K256K280K359K
Working Capital Changes8M3.15M3.98M17.14M-----181K-1.91M-6.24M-2M1.44M2.42M967K2.36M268K8.34M-6.13M
Change in Receivables0000-----00000000000
Change in Inventory0000-----00000000000
Change in Payables2.6M2.66M375K17.13M------941K-37K-2.77M-1.08M2.01M200K1.44M-908K-400K1.68M-449K
Cash from Investing-178.75M00-17.37M-----6M5.65M9.58M8.29M3.09M1.37M14.33M8.31M-51K-10.21M14.41M
Capital Expenditures0000-----000000-41K-138K26K-43K4K
CapEx % of Revenue--------------------
Acquisitions0000-----00000070K0000
Investments--------------------
Other Investing750K000-----0083K000-70K0000
Cash from Financing5.12M29.5M295.92M266.84M-----000171K2.68M23K65K424K18K00
Debt Issued (Net)0000-----00000000000
Equity Issued (Net)5.12M29.5M295.92M266.84M-----000171K2.68M23K65K424K18K00
Dividends Paid0000-----00000000000
Share Repurchases0000-----00000000000
Other Financing0000-----00000000000
Net Change in Cash-190.86M7.62M275.27M250.02M-----1.77M-374K-1.61M122K-2.11M-7.72M4.45M-1.46M-15.59M-17.18M-3.59M
Free Cash Flow-17.23M-21.87M-20.6M566K------4.1M-5.94M-11.47M-8.45M-7.85M-9.13M-11.49M-9.98M-14.81M-6.84M-17.82M
FCF Margin %--------------------
FCF Growth %----------35.01%0.13%15.33%47.02%-33.54%35.55%-8.46%-31.28%51.89%-22.79%
FCF per Share-1.05-0.36-0.600.34------3.78-5.53-10.58-7.80-7.44-8.89-11.20-9.79-14.66-6.77-17.64
FCF Conversion (FCF/Net Income)0.54x0.70x0.74x-0.00x-----0.77x1.08x1.77x1.04x0.73x0.70x0.81x0.72x0.88x0.40x1.33x
Interest Paid0000-----00000000000
Taxes Paid0000-----00000000000